Plants as a source of anti-cancer agents

被引:1368
作者
Cragg, GM [1 ]
Newman, DJ [1 ]
机构
[1] NCI, Nat Prod Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21702 USA
关键词
camptothecins; combretastatins; flavopiridol; podophyllotoxins; taxanes; vinca alkaloids; cell cycle target inhibitor;
D O I
10.1016/j.jep.2005.05.011
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Plant-derived compounds have been an important source of several clinically useful anti-cancer agents. These include vinblastine, vincristine, the camptothecin derivatives, topotecan and irinotecan, etoposide. derived froth epipodophyllotoxin, and paclitaxel (taxol(R)). A number of promising new agents are in clinical development based on selective activity against cancer-related molecular targets, including flavopiridol and combretastin A4 phosphate, while some agents which failed in earlier clinical studies are stimulating renewed interest. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 28 条
[1]  
[Anonymous], PLANTS USED CANC
[2]  
Cassady J.M., 1980, ANTICANCER AGENTS BA
[3]   Recent developments in the maytansinoid antitumor agents [J].
Cassady, JM ;
Chan, KK ;
Floss, HG ;
Leistner, E .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (01) :1-26
[4]  
CHANG RK, 1999, AM PHARM REV, V2, P6
[5]   Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection [J].
Cichewicz, RH ;
Kouzi, SA .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :90-114
[6]   Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action [J].
Couch, RD ;
Browning, RG ;
Honda, T ;
Gribble, GW ;
Wright, DL ;
Sporn, MB ;
Anderson, AC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) :2215-2219
[7]  
Cragg G. M., 2005, ANTICANCER AGENTS NA
[8]   A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy [J].
Cragg, GM ;
Newman, DJ .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (02) :232-244
[9]   Antitumor activity of bruceantin: An old drug with new promise [J].
Cuendet, M ;
Pezzuto, JM .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (02) :269-272
[10]   Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer [J].
Denmeade, SR ;
Jakobsen, CM ;
Janssen, S ;
Khan, SR ;
Garrett, ES ;
Lilja, H ;
Christensen, SB ;
Isaacs, JT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :990-1000